GR1501 Injection

· Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GR1501 Injection, covering 2023-04-05 to 2023-04-05. Get the full timeline:

Most recent: Clinical Trial Update: to Evaluate the Preliminary Efficacy and Safety of GR1501 Injection in Patients With Active Axial Spondyloarthritis [Phase 2]

See pricing